Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IKT Inhibikase Therapeutics

Watchlist
0.489
-0.051-9.44%
Trading Session  12/08 12:30 ET
High
0.540
Open
0.530
Turnover
57.23K
Low
0.477
Pre Close
0.540
Volume
114.47K
Market Cap
12.34M
P/E(TTM)
Loss
52wk High
1.800
Shares
25.23M
P/E(Static)
Loss
52wk Low
0.440
Float Cap
8.94M
Bid/Ask %
0.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
10.62
Historical Low
0.440
Dividend TTM
--
Div Yield TTM
--
P/B
0.49
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.63%
Amplitude
11.63%
Avg Price
0.499
Lot Size
1
Float Cap
8.94M
Bid/Ask %
0.00%
Historical High
11.800
Shs Float
18.29M
Volume Ratio
10.62
Historical Low
0.440
Dividend TTM
--
P/B
0.49
Dividend LFY
--
Turnover Ratio
0.63%
Amplitude
11.63%
Avg Price
0.499
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP? Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
CEO: Dr. Milton H. Werner, PhD
Market: NASDAQ
Listing Date: 12/23/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist